Option chain shows key data for Capital Venture Europe PLC's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Capital Venture Europe PLC.

Capital Venture Europe PLC (OTC:CPVNF) Stock, Option Chain

Capital Venture Europe PLC

Magyar Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGYR#NASDAQ">MGYR</a>) reported quarterly earnings of $0.33 per share. This is a 26.92 percent increase over earnings of $0.26 per share from the same period last year.

Earnings

News

MGYR

Magyar Bancorp Q1 EPS $0.33 Up From $0.26 YoY

Dividends

Buybacks

EWBC

East West Bancorp Announces Incremental $300M Share Repurchase And 9% Increase To Common Stock Dividend

Covenant Logistics Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVLG#NASDAQ">CVLG</a>) reported quarterly earnings of $0.49 per share which missed the analyst consensus estimate of $0.50 by 2 percent. This is a 9.26 percent decrease over earnings of $0.54 per share from the same period last year. The company reported quarterly sales of $277.330 million which missed the analyst consensus estimate of $284.907 million by 2.66 percent. This is a 1.22 percent increase over sales of $273.985 million the same period last year.

Earnings Misses

CVLG

Covenant Logistics Gr Q4 2024 Adj. EPS $0.49 Misses $0.50 Estimate, Sales $277.330M Miss $284.907M Estimate

<h3>Gainers</h3>
<ul>
<li>Exicure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XCUR#NASDAQ">XCUR</a>) stock increased by 43.9% to $14.92 during Thursday's pre-market session. The market value of their outstanding shares is at $45.3 million. </li>
<li>Hepion Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HEPA#NASDAQ">HEPA</a>) shares moved upwards by 42.88% to $0.19. The market value of their outstanding shares is at $1.3 million. </li>
<li>Oncology Institute (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TOI#NASDAQ">TOI</a>) shares increased by 13.54% to $0.8. The market value of their outstanding shares is at $60.3 million. </li>
<li>Inogen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INGN#NASDAQ">INGN</a>) shares moved upwards by 12.74% to $12.21. The company's market cap stands at $290.8 million. </li>
<li>IN8bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INAB#NASDAQ">INAB</a>) shares rose 12.53% to $0.29. The market value of their outstanding shares is at $21.0 million. </li>
<li>Vigil Neuroscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIGL#NASDAQ">VIGL</a>) shares moved upwards by 12.31% to $2.28. The company's market cap stands at $93.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>ALX Oncology Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALXO#NASDAQ">ALXO</a>) shares fell 16.7% to $1.5 during Thursday's pre-market session. The company's market cap stands at $79.1 million. </li>
<li>Jupiter Neurosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JUNS#NASDAQ">JUNS</a>) shares decreased by 14.53% to $3.06. The market value of their outstanding shares is at $101.2 million. </li>
<li>Channel Therapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CHRO#AMEX">CHRO</a>) shares fell 11.48% to $2.39. The company's market cap stands at $14.4 million. </li>
<li>Sonnet BioTherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SONN#NASDAQ">SONN</a>) shares fell 10.0% to $1.8. The company's market cap stands at $5.4 million. </li>
<li>Aspira Womens Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AWH#NASDAQ">AWH</a>) shares decreased by 8.98% to $0.4. The company's market cap stands at $7.0 million. </li>
<li>Helius Medical Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSDT#NASDAQ">HSDT</a>) stock fell 8.91% to $0.75. The market value of their outstanding shares is at $2.7 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

ALXO

CHRO

HEPA

HSDT

INAB

INGN

JUNS

SONN

VIGL

XCUR

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Metropolitan Bank Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCB#NYSE">MCB</a>) reported quarterly earnings of $1.88 per share which beat the analyst consensus estimate of $1.42 by 32.39 percent.

Earnings Beats

Metropolitan Bank Holding Q4 2024 Adj EPS $1.88 Beats $1.42 Estimate

<h3>Gainers</h3>
<ul>
<li>SES AI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SES#NYSE">SES</a>) stock increased by 30.5% to $1.08 during Thursday's pre-market session. The company's market cap stands at $388.0 million. </li>
<li>Stardust Power (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDST#NASDAQ">SDST</a>) stock increased by 21.7% to $2.35. The company's market cap stands at $112.7 million. </li>
<li>Knight-Swift (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KNX#NYSE">KNX</a>) stock moved upwards by 11.61% to $61.39. The market value of their outstanding shares is at $9.9 billion. As per the press release, Q4 earnings came out yesterday. </li>
<li>LSI Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYTS#NASDAQ">LYTS</a>) stock increased by 11.47% to $22.05. The market value of their outstanding shares is at $657.9 million. As per the news, the Q2 earnings report came out today. </li>
<li>OneConstruction Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONEG#NASDAQ">ONEG</a>) shares moved upwards by 10.41% to $2.65. The company's market cap stands at $34.4 million. </li>
<li>Sunrise New Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EPOW#NASDAQ">EPOW</a>) shares increased by 8.5% to $0.97. The market value of their outstanding shares is at $25.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Vertical Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVTL#NYSE">EVTL</a>) stock declined by 37.8% to $5.77 during Thursday's pre-market session. The company's market cap stands at $401.2 million. </li>
<li>ConnectM Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNTM#NASDAQ">CNTM</a>) shares declined by 9.33% to $1.07. The company's market cap stands at $22.7 million. </li>
<li>Mynaric (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYNA#NASDAQ">MYNA</a>) stock declined by 8.49% to $0.5. The company's market cap stands at $12.7 million. </li>
<li>Sentage Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNTG#NASDAQ">SNTG</a>) shares fell 7.41% to $2.0. The company's market cap stands at $5.6 million. </li>
<li>Construction Partners (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROAD#NASDAQ">ROAD</a>) shares decreased by 7.32% to $85.99. The company's market cap stands at $4.8 billion. </li>
<li>American Airlines Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAL#NASDAQ">AAL</a>) shares declined by 7.03% to $17.35. The market value of their outstanding shares is at $11.4 billion. As per the press release, Q4 earnings came out today. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CNTM

Sunrise New Energy Co., Ltd - Ordinary Shares

EPOW

EVTL

LYTS

MYNA

ONEG

ROAD

SDST

SNTG

12 Industrials Stocks Moving In Thursday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Kopin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KOPN#NASDAQ">KOPN</a>) shares rose 29.9% to $1.91 during Thursday's pre-market session. The market value of their outstanding shares is at $292.7 million. </li>
<li>Evolv Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVLV#NASDAQ">EVLV</a>) shares increased by 13.97% to $3.67. The market value of their outstanding shares is at $578.2 million. </li>
<li>U-BX Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UBXG#NASDAQ">UBXG</a>) stock increased by 13.01% to $3.3. The company's market cap stands at $11.1 million. </li>
<li>Coda Octopus Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CODA#NASDAQ">CODA</a>) stock increased by 10.22% to $9.38. The company's market cap stands at $105.0 million. </li>
<li>Alpha Modus Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMOD#NASDAQ">AMOD</a>) stock rose 9.29% to $2.02. The market value of their outstanding shares is at $26.7 million. </li>
<li>VerifyMe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRME#NASDAQ">VRME</a>) stock rose 7.91% to $2.59. The company's market cap stands at $27.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Bit Origin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTOG#NASDAQ">BTOG</a>) stock fell 10.1% to $0.53 during Thursday's pre-market session. The company's market cap stands at $4.4 million. </li>
<li>Plexus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLXS#NASDAQ">PLXS</a>) stock declined by 9.15% to $154.9. The market value of their outstanding shares is at $4.1 billion. The company's, Q1 earnings came out yesterday. </li>
<li>Mobix Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOBX#NASDAQ">MOBX</a>) shares declined by 9.04% to $1.51. The market value of their outstanding shares is at $55.7 million. </li>
<li>Sobr Safe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOBR#NASDAQ">SOBR</a>) shares declined by 8.66% to $0.95. </li>
<li>Ondas Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONDS#NASDAQ">ONDS</a>) stock declined by 7.6% to $2.19. The market value of their outstanding shares is at $210.0 million. </li>
<li>Blackboxstocks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLBX#NASDAQ">BLBX</a>) stock fell 7.43% to $5.11. The market value of their outstanding shares is at $18.0 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMOD

BLBX

BTOG

CODA

EVLV

KOPN

MOBX

ONDS

PLXS

SOBR

UBXG

VRME

12 Information Technology Stocks Moving In Thursday's Pre-Market Session

East West Bancorp Q4 2024 GAAP EPS $2.10 Misses $2.11 Estimate

FVCBankcorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FVCB#NASDAQ">FVCB</a>) reported quarterly earnings of $0.26 per share which met the analyst consensus estimate. This is a 23.81 percent increase over earnings of $0.21 per share from the same period last year. The company reported quarterly sales of $14.91 million which beat the analyst consensus estimate of $14.65 million by 1.80 percent. This is a 17.81 percent increase over sales of $12.66 million the same period last year.

FVCB

FVCBankcorp Q4 Adj $0.26, Inline, Sales $14.91M Beat $14.65M Estimate

WIIM

ISRG

Intuitive Surgical shares are trading higher after the company reported better-than-expected Q4 financial results.

Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) reported quarterly earnings of $2.21 per share which beat the analyst consensus estimate of $1.79 by 23.46 percent. This is a 38.12 percent increase over earnings of $1.60 per share from the same period last year. The company reported quarterly sales of $2.41 billion which beat the analyst consensus estimate of $2.25 billion by 7.22 percent. This is a 25.14 percent increase over sales of $1.93 billion the same period last year.

Intuitive Surgical Q4 2024 Adj EPS $2.21 Beats $1.79 Estimate, Sales $2.41B Beat $2.25B Estimate

CSX (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSX#NASDAQ">CSX</a>) released its Q4 earnings on Thursday, January 23, 2025 at 04:01 PM.
Here's what's important from the earnings announcement.
<h3>Earnings</h3>
CSX missed estimated earnings by 0.0%, reporting an EPS of $0.42 versus an estimate of $0.42.
Revenue was down $140.00 million from the same period last year.
<h3>Earnings History Overview</h3>
The company missed on EPS by $0.02 in the last quarter, resulting in a 7.000000000000001% drop share price change the following day.
Here's a look at CSX's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.48</td>
<td>0.48</td>
<td>0.45</td>
<td>0.44</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.46</td>
<td>0.49</td>
<td>0.46</td>
<td>0.45</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>3.67B</td>
<td>3.70B</td>
<td>3.66B</td>
<td>3.63B</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>3.62B</td>
<td>3.70B</td>
<td>3.68B</td>
<td>3.68B</td>
</tr>
</tbody>
</table>

To track all earnings releases for CSX <a href="https://www.benzinga.com/quote/CSX/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CSX Earnings Report: Q4 Overview

Columbia Banking System (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COLB#NASDAQ">COLB</a>) released its Q4 earnings on Thursday, January 23, 2025 at 04:02 PM.
Here's what's important from the earnings announcement.
<h3>Earnings</h3>
Columbia Banking System beat estimated earnings by 9.0%, reporting an EPS of $0.71 versus an estimate of $0.65.
Revenue was down $32.04 million from the same period last year.
<h3>Analysis of Past Earnings</h3>
Last quarter the company beat on EPS by $0.07 which was followed by a 1.0% drop in the share price the next day.
Here's a look at Columbia Banking System's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.62</td>
<td>0.57</td>
<td>0.53</td>
<td>0.79</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.69</td>
<td>0.67</td>
<td>0.65</td>
<td>0.44</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>481.03M</td>
<td>475.95M</td>
<td>480.36M</td>
<td>526.68M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>496.38M</td>
<td>472.15M</td>
<td>473.72M</td>
<td>519.16M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Columbia Banking System <a href="https://www.benzinga.com/quote/COLB/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

COLB

Recap: Columbia Banking System Q4 Earnings

Texas Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>) reported its Q4 earnings results on Thursday, January 23, 2025 at 04:01 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Texas Instruments beat estimated earnings by 8.0%, reporting an EPS of $1.3 versus an estimate of $1.2.
Revenue was down $70.00 million from the same period last year.
<h3>Previous Earnings Records</h3>
Last quarter the company beat on EPS by $0.09 which was followed by a 4.0% increase in the share price the next day.
Here's a look at Texas Instruments's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.38</td>
<td>1.17</td>
<td>1.07</td>
<td>1.46</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.47</td>
<td>1.22</td>
<td>1.20</td>
<td>1.49</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>4.12B</td>
<td>3.82B</td>
<td>3.61B</td>
<td>4.12B</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>4.15B</td>
<td>3.82B</td>
<td>3.66B</td>
<td>4.08B</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
Texas Instruments management provided guidance for Q1 2025, expecting earnings between $0.94 and $1.16 per share.
To track all earnings releases for Texas Instruments <a href="https://www.benzinga.com/quote/TXN/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Texas Instruments Earnings Analysis: Q4 Recap

Community West Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CWBC#NASDAQ">CWBC</a>) reported quarterly earnings of $0.36 per share. This is a 28 percent decrease over earnings of $0.50 per share from the same period last year.

CWBC

Community West Bancshares Q4 EPS $0.36 Down From $0.50 YoY

Columbia Banking System (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COLB#NASDAQ">COLB</a>) reported quarterly earnings of $0.71 per share which beat the analyst consensus estimate of $0.65 by 9.23 percent.&nbsp;

Columbia Banking System Q4 2024 Adj EPS $0.71 Beats $0.65 Estimate

CSX shares are trading lower following mixed Q4 financial results.

<ul>
<li>"TI's first quarter outlook is for revenue in the range of $3.74 billion to $4.06 billion and earnings per share between $0.94 and $1.16. We now expect our 2025 effective tax rate to be about 12%."</li>
</ul>

Guidance

Texas Instruments Q1 Outlook For Revenue In The Range Of $3.74B-$4.06B Vs $3.874B Est.; EPS Between $0.94-$1.16 Vs $1.17 Est; Now Expect Our 2025 Effective Tax Rate To Be About 12%

Business First Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BFST#NASDAQ">BFST</a>) reported quarterly earnings of $0.51 per share which beat the analyst consensus estimate of $0.49 by 4.08 percent. This is a 22.73 percent decrease over earnings of $0.66 per share from the same period last year.

BFST

Business First Bancshares Q4 2024 Adj. EPS $0.51 Beats $0.49 Estimate

NVNI

Nuvini Receives Written Notice That It Regained Compliance With Nasdaq Minimum Bid Price Listing Requirements

Comments

Capital Venture Europe PLC

Capital Venture Europe PLC (CPVNF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga